Diagnostic Imaging is used through out the diagnosis and treatment of Neuroendocrince Tumours. Standard scans include:
Additonal scans include:
Bone scan: This test detects the damage to the bone including trauma and infection; it can also find if cancer has spread to the bones. A radioactive tracer is injected to enable pictures to be taken by our SPECT/CT scanner.
mIBG scan: mIBG is injected as the radioactive tracer for this scan. The scan shows the doctor how certain organs are working and helps identify abnormalities. The scan takes place over 2 days with pictures taken on the first and more detailed ones on the second day. There are two different scans for NETs:
- Gallium 68 Octreotate PET scan: Gallium 68 is a radioactive tracer attached to octreotide. It is injected intravenously and is a very specific for identifying neuroendocrine tumour cells.
- FDG PET scan: An abbreviation for fluorodeoxyglucose, the tracer injected for this scan using a PET/CT scanner. The scan identifies the presence of a metabolically active tumour (usually a higher grade tumour) within the body.
Octreo Scan: Is a nuclear medicine scan which uses a radioactive substance Indiem III attached to Octreotide to find tumours. A small amount of Indiem III Octreotide is injected to highlight a tumour to enable pictures to be taken by our SPECT/CT scanner.